comparemela.com

Latest Breaking News On - Phillip chan - Page 4 : comparemela.com

CytoSorbents Announces Kathleen P. Bloch To Resume as Full-Time Chief Financial Officer

PRINCETON, N.J., Sept. 19, 2023 CytoSorbents Corporation , a critical care therapy leader commercializing its CytoSorb® blood purification technology to treat cytokine storm and deadly.

Canada
United-states
Canadian
Phillip-chan
Kathleenp-bloch
Alexander-damico
Kathleen-bloch
Human-services
European-union
Cytosorbents-corporation
Facebook
National-institutes-of-health

Cytosorbents (CTSO) Announces Kathleen P. Bloch To Resume as Full-Time Chief Financial Officer

Cytosorbents (CTSO) Announces Kathleen P. Bloch To Resume as Full-Time Chief Financial Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Canada
United-states
Canadian
Kathleenp-bloch
Phillip-chan
Alexander-damico
National-heart
Us-department-of-health
Blood-institute
Twitter
Us-air
Material-command

CytoSorb with Ex Vivo Organ Perfusion: Transforming the Future of Solid Organ Transplantation -Today at 11:33 am

In the first human retrospective study, CytoSorb and ex vivo lung perfusion prior to lung transplant increased in-hospital and one-year survivalPRINCETON, N.J., Sept. 11, 2023 CytoSorbents.

Zurich
Züsz
Switzerland
Sweden
Italy
Phillip-chan
Sandra-lindstedt
Kathleen-bloch
Massimo-boffini
European-union
Cytosorbents-corporation
Lund-university-hospital

Cytosorbents : Q2 2023 Press Release -Today at 04:45 am

CytoSorbents Reports Second Quarter 2023 Financial and Operational Results Q2 2023 Total Revenue was $9.4 million, an 11% increase from $8.5.

Canada
Canadian
Humedic-limax
Michael-bator
Eli-lilly
Kathy-bloch
Phillip-chan
Daiichi-sankyo
Al-krausas
Health-canada
Healthcare-research-at-jennison-associates
Partner-of-quartz-advisory-group

Cytosorbents : Q4 and Full Year 2022 Press Release -Today at 04:45 am

CytoSorbents Reports Fourth Quarter and Full Year 2022 Results Pivotal U.S. and Canada STAR-T Trial enrollment passes halfway mark. Positive sales .

Canada
Paris
France-general
France
Germany
Canadian
Richard-whitlock
Irina-kulinets
Phillip-chan
Vince-capponi
Jim-komsa
Canada-research

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.